6 Vasodilators and Integrated Cardiovascular Medication Practice
Learn how to recognize important cardiovascular medication interactions, adverse effects, contraindications, and monitoring needs in patient-care scenarios.
Responding safely to medication risks
Medication safety depends on considering the patient’s medicines, symptoms, relevant history, and laboratory results together. Follow the prescribed plan and local clinical protocols, and promptly report urgent symptoms. Do not independently substitute, stop, or change cardiovascular medication doses; contact the prescriber or treating clinician for direction.
Nitrates and sildenafil
taken with a phosphodiesterase-5 inhibitor such as sildenafil can cause severe hypotension, fainting, or myocardial ischemia. If a patient with angina reports taking sildenafil earlier that day, do not give . Promptly contact the prescriber or emergency team for guidance, especially if the patient has active chest pain; lying down or giving a reduced dose does not replace escalation for clinical guidance.
and systemic symptoms
Long-term use can cause a lupus-like reaction, sometimes involving the kidneys. New joint pain, fever, and a persistent rash should be promptly reported to the prescriber for assessment. Do not dismiss these symptoms as expected or change the medication without clinician direction.
Diuretics, fluid loss, and potassium
Furosemide, a loop diuretic, can lower potassium. Excessive diuresis can also cause dehydration, low blood pressure, and electrolyte disturbances. Dizziness on standing, muscle cramps, or marked thirst should prompt assessment rather than being dismissed as proof that the medication is working.
Assessment may include blood pressure, fluid status, kidney function, and electrolytes. Furosemide treatment calls for clinical monitoring of electrolytes and kidney function; do not advise restricting all fluids or increasing the dose without clinical review.
Medicines and potassium balance
and ACE inhibitors such as lisinopril can raise potassium. A potassium-containing salt substitute can add to this risk, particularly when kidney function is impaired. Advise the patient not to start the substitute without clinician approval, and arrange appropriate potassium and kidney-function monitoring.
Check potassium after starting or increasing and monitor it regularly. Loop diuretics such as furosemide can lower potassium, so the patient’s medication combination and test results matter; do not assume that the medicines cancel one another’s effects.
toxicity and electrolyte changes
Low potassium can increase the heart’s sensitivity to , and impaired kidney function can increase the risk of toxicity. Nausea and unusual yellow-green visual changes in a patient taking —especially with low potassium while also taking furosemide—warrant prompt clinician notification and assessment of possible toxicity and electrolyte disturbance.
Interpret symptoms and laboratory results together. Decisions about holding or changing doses belong to the treating clinician; do not reassure the patient that low potassium prevents toxicity or tell them to stop all cardiovascular medicines permanently.
interactions and monitoring
When is prescribed for a patient taking warfarin and , review the combination with the prescriber and arrange closer , , and heart-rate monitoring. can increase exposure and intensify slow heart rate or conduction problems. It can also increase warfarin’s anticoagulant effect, raising bleeding risk.
The prescriber may need to adjust therapy and monitoring. Do not wait for symptoms before arranging review, and do not independently stop warfarin or or add another antiarrhythmic.
, conduction, and airway risks
is contraindicated in patients with second- or third-degree AV block who do not have a functioning pacemaker, and in patients with bronchoconstrictive or bronchospastic lung disease such as asthma. If a patient being considered for IV has asthma and second-degree AV block, withhold it and immediately alert the treating clinician.
can cause transient or more serious conduction block. When it is used, appropriate monitoring and resuscitative capability are important; its brief effects do not remove the need to consider contraindications and risks.